XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -3.69%482.08M | -4.38%162.79M | -9.97%79.67M | -18.45%174.08M | 131.14%65.54M | 111.12%500.57M | 7.02%170.26M | 986.96%88.5M | 57.91%213.46M | 143.43%28.36M |
Net income from continuing operations | -61.51%111.33M | -89.82%14.93M | 97.97%39.18M | -23.04%20.7M | -61.90%36.52M | 943.45%289.24M | 4,112.52%146.72M | -35.49%19.79M | 209.30%26.9M | 318.57%95.83M |
Operating gains losses | 72.49%-12.22M | 103.96%1.38M | 46.98%-2.66M | -1,011.67%-8.21M | 50.67%-2.74M | -6.43%-44.42M | -107.24%-34.76M | 49.77%-5.01M | 114.92%900K | 38.04%-5.55M |
Depreciation and amortization | 3.95%309.31M | 4.41%82.21M | 2.57%75.07M | -0.36%73.82M | 9.32%78.21M | 6.64%297.56M | 10.31%78.73M | 5.39%73.19M | 6.21%74.09M | 4.51%71.54M |
Deferred tax | 284.23%43.23M | 108.33%5.72M | 75.73%13.88M | -44.05%10.51M | -28.90%13.12M | -216.45%-23.47M | -838.70%-68.6M | 24.93%7.9M | 390.73%18.79M | 2,488.36%18.46M |
Other non cash items | -25.11%69.48M | -45.31%15.89M | -13.65%16.94M | -13.72%18.28M | -19.86%18.37M | 5.00%92.78M | 22.12%29.05M | -12.88%19.62M | -0.61%21.19M | 10.56%22.92M |
Change In working capital | 156.98%18.71M | 68.58%42.26M | -982.63%-33.65M | -18.53%62.33M | 60.23%-52.22M | 28.44%-32.84M | -47.50%25.07M | 95.75%-3.11M | 2.27%76.5M | -37.85%-131.3M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -3.69%482.08M | -4.38%162.79M | -9.97%79.67M | -18.45%174.08M | 131.14%65.54M | 111.12%500.57M | 7.02%170.26M | 986.96%88.5M | 57.91%213.46M | 143.43%28.36M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 5.49%-202.99M | -7.51%-61.95M | -13.34%-38.85M | 38.85%-26.94M | 4.54%-75.24M | -48.73%-214.78M | -26.43%-57.63M | -8.09%-34.28M | -19.79%-44.06M | -159.75%-78.82M |
Net PPE purchase and sale | 7.39%-186.25M | 33.31%-50.33M | -29.66%-58.15M | 27.39%-27.43M | -16.99%-50.34M | -36.77%-201.12M | -44.72%-75.47M | -55.91%-44.85M | -15.92%-37.78M | -28.24%-43.03M |
Net intangibles purchase and sale | 97.15%-51K | --0 | 93.98%-51K | --0 | ---- | ---1.79M | ---265K | ---847K | ---677K | ---- |
Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | -180.84%-28.65M | ---646K | --0 | --0 | ---28M |
Net investment purchase and sale | -37.94%2.9M | -1,077.05%-718K | -100.10%-7K | 279.71%3.62M | --0 | 856.89%4.67M | -662.50%-61K | 9,417.81%6.8M | -276.12%-2.02M | ---55K |
Net other investing changes | -261.83%-19.58M | -157.98%-10.91M | 319.41%19.36M | 12.75%-3.14M | -221.99%-24.9M | -10.06%12.1M | 186.17%18.81M | -37.02%4.62M | 1.80%-3.59M | -340.72%-7.73M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 5.49%-202.99M | -7.51%-61.95M | -13.34%-38.85M | 38.85%-26.94M | 4.54%-75.24M | -48.73%-214.78M | -26.43%-57.63M | -8.09%-34.28M | -19.79%-44.06M | -159.75%-78.82M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -3.74%-261.39M | 50.27%-53.07M | -127.16%-64.35M | 30.75%-129.97M | -119.78%-14M | -122.64%-251.97M | 18.19%-106.71M | -411.35%-28.33M | -162.15%-187.68M | -11.30%70.75M |
Net issuance payments of debt | 14.59%-189.61M | 68.79%-28M | -84.78%-52.34M | 41.38%-105.35M | -105.17%-3.92M | -96.48%-222.01M | 33.11%-89.71M | -300.79%-28.33M | -151.86%-179.72M | -3.35%75.74M |
Net common stock issuance | -152.00%-75.49M | -47.16%-25.02M | ---16.89M | -195.21%-23.49M | -101.90%-10.08M | -199.25%-29.96M | ---17M | --0 | -59.16%-7.96M | ---4.99M |
Proceeds from stock option exercised by employees | --686K | --0 | --495K | --191K | ---- | --0 | --0 | --0 | --0 | ---- |
Net other financing activities | --3.03M | ---46K | --4.39M | ---1.32M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -3.74%-261.39M | 50.27%-53.07M | -127.16%-64.35M | 30.75%-129.97M | -119.78%-14M | -122.64%-251.97M | 18.19%-106.71M | -411.35%-28.33M | -162.15%-187.68M | -11.30%70.75M |
Net cash flow | ||||||||||
Beginning cash position | 150.99%54.18M | -50.47%24.3M | 110.45%48.23M | -25.64%30.95M | 150.99%54.18M | -46.81%21.59M | 22.52%49.07M | -55.62%22.92M | 72.68%41.62M | -46.81%21.59M |
Current changes in cash | -47.63%17.71M | 707.56%47.77M | -190.85%-23.53M | 193.89%17.16M | -216.76%-23.69M | 265.13%33.82M | 134.92%5.92M | 278.94%25.9M | -168.21%-18.28M | 227.82%20.29M |
Effect of exchange rate changes | 253.10%1.88M | 313.03%1.7M | -260.56%-403K | 129.22%123K | 277.13%457K | -182.78%-1.23M | 47.64%-798K | -91.28%251K | -156.97%-421K | 57.84%-258K |
End cash Position | 36.15%73.77M | 36.15%73.77M | -50.47%24.3M | 110.45%48.23M | -25.64%30.95M | 150.99%54.18M | 150.99%54.18M | 22.52%49.07M | -55.62%22.92M | 72.68%41.62M |
Free cash flow | -3.08%265.39M | 13.66%103.89M | -56.17%15.83M | -19.61%135.65M | 144.64%10.02M | 418.07%273.82M | -10.18%91.41M | 184.05%36.11M | 76.26%168.75M | 77.94%-22.44M |
Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |